Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 2
1981 2
1983 2
1984 2
1987 1
1988 1
1989 1
1990 1
1991 1
1992 2
1993 1
1995 2
1996 1
1998 1
2003 1
2004 1
2005 1
2006 1
2008 1
2009 3
2010 1
2012 1
2013 1
2014 1
2017 1
2019 1
2020 1
2021 1
2022 1
2023 1
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Management of carpal tunnel syndrome in primary care.
Kjeken I, Sundin U. Kjeken I, et al. Among authors: sundin u. Rheumatology (Oxford). 2023 Feb 1;62(2):495-496. doi: 10.1093/rheumatology/keac396. Rheumatology (Oxford). 2023. PMID: 35894646 No abstract available.
Subclinical inflammation and joint damage progression in patients with early RA fulfilling 2011 vs 2022 ACR/EULAR Boolean remission criteria: data from the ARCTIC study.
Melokhina V, Paulshus Sundlisæter N, Sexton J, Sundin U, Aga AB, Kjørholt KE, Nordberg LB, van der Heijde D, Haavardsholm E, Lillegraven S. Melokhina V, et al. Among authors: sundin u. Ann Rheum Dis. 2024 Mar 12;83(4):540-541. doi: 10.1136/ard-2023-224950. Ann Rheum Dis. 2024. PMID: 38049997 No abstract available.
Inflammation and biologic therapy in patients with rheumatoid arthritis achieving versus not achieving ACR/EULAR Boolean remission in a treat-to-target study.
Paulshus Sundlisæter N, Sundin U, Aga AB, Sexton J, Hammer HB, Uhlig T, Kvien TK, Haavardsholm EA, Lillegraven S. Paulshus Sundlisæter N, et al. Among authors: sundin u. RMD Open. 2022 Jan;8(1):e002013. doi: 10.1136/rmdopen-2021-002013. RMD Open. 2022. PMID: 35091463 Free PMC article. Clinical Trial.
Value of MRI and ultrasound for prediction of therapeutic response and erosive progression in patients with early rheumatoid arthritis managed by an aggressive treat-to-target strategy.
Sundin U, Sundlisater NP, Aga AB, Sexton J, Nordberg LB, Hammer HB, van der Heijde D, Kvien TK, Haavardsholm EA, Lillegraven S; the ARCTIC Study Group. Sundin U, et al. RMD Open. 2021 Feb;7(1):e001525. doi: 10.1136/rmdopen-2020-001525. RMD Open. 2021. PMID: 33547228 Free PMC article.
HLA-DRB1*04/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus.
Lundström E, Gustafsson JT, Jönsen A, Leonard D, Zickert A, Elvin K, Sturfelt G, Nordmark G, Bengtsson AA, Sundin U, Källberg H, Sandling JK, Syvänen AC, Klareskog L, Gunnarsson I, Rönnblom L, Padyukov L, Svenungsson E. Lundström E, et al. Among authors: sundin u. Ann Rheum Dis. 2013 Jun;72(6):1018-25. doi: 10.1136/annrheumdis-2012-201760. Epub 2012 Aug 14. Ann Rheum Dis. 2013. PMID: 22893315
Conventional versus ultrasound treat to target: no difference in magnetic resonance imaging inflammation or joint damage over 2 years in early rheumatoid arthritis.
Sundin U, Aga AB, Skare Ø, Nordberg LB, Uhlig T, Hammer HB, van der Heijde D, Kvien TK, Lillegraven S, Haavardsholm EA; ARCTIC study group. Sundin U, et al. Rheumatology (Oxford). 2020 Sep 1;59(9):2550-2555. doi: 10.1093/rheumatology/kez674. Rheumatology (Oxford). 2020. PMID: 31999341 Clinical Trial.
36 results